FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
24,686,474
Share change
+1,508,727
Total reported value
$892,383,878
Put/Call ratio
149%
Price per share
$36.15
Number of holders
155
Value change
+$38,075,158
Number of buys
75
Number of sells
97

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q1 2017

As of 31 Mar 2017, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 155 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,686,474 shares. The largest 10 holders included FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, BB BIOTECH AG, EVENTIDE ASSET MANAGEMENT, LLC, and VICTORY CAPITAL MANAGEMENT INC. This page lists 155 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.